TIGIT and neoplasm: In these patients, the expression of TIM-3, TIGIT, PD-1, and CD39 on Vδ1 cells varied among PBLs, MALs, and tumor-infiltrating lymphocytes (TILs), depending on the tumor microenvironment [31].